MedPath

A randomized, bilateral, controlled, prospective study to investigate the efficacy of corneal shape customised versus standard whole central cornea riboflavin/ultraviolet A corneal collagen cross-linking

Not Applicable
Conditions
Keratoconus, corneal ectasia
Eye Diseases
Keratoconus
Registration Number
ISRCTN52187987
Lead Sponsor
Guy's and St Thomas' NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
All
Target Recruitment
34
Inclusion Criteria

1. Progressive keratoconus defined by an increase in refractive astigmatism, maximum keratometry, apex power of the cone by more than 1 diopter and/or a decrease in central corneal pachymetry by 10% in the preceding 2 years to 18 months
2. Grade I-III keratoconus (3mm keratometry less than 55 diopters, cone apex power less than 70 diopters, central pachymetry greater than 400um)
3. Age over 18

Exclusion Criteria

1. Advanced keratoconus (3mm keratometry greater than 55 diopters, cone apex power greater than 70 diopters, central pachymetry less than 400um)
2. Pregnancy
3. Corneal scarring
4. Co-existant ocular pathology other than keratoconus
5. Age less than 18

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Change in:<br> 1. Refractive error (diopters)<br> 2. Topographic simulated keratometry (diopters) (corneal curvature)<br> 3. Maximum keratometry (Kmax)<br> 4. Posterior corneal curvature<br> 5. Pentacam-derived keratoconus indices<br> 6. Belin-Ambrosio enhanced ectasia scores<br> 7. Corneal pachymetry (micrometers)<br> 8. Visual acuity (logMar)<br> Measured at baseline 6, 12 and 18 months<br>
Secondary Outcome Measures
NameTimeMethod
<br> Stability in:<br> 1. Refractive error (diopters)<br> 2. Topographic simulated keratometry (diopters) (corneal curvature)<br> 3. Maximum keratometry (Kmax)<br> 4. Posterior corneal curvature<br> 5. Pentacam-derived keratoconus indices<br> 6. Belin-Ambrosio enhanced ectasia scores<br> 7. Corneal pachymetry (micrometers)<br> 8. Visual acuity (logMar)<br> 9. Endothelial cell counts<br> 10. Sight-threatening complications<br> Measured at baseline 6, 12 and 18 months<br>
© Copyright 2025. All Rights Reserved by MedPath